Main Article Content


Background: DM, especially type 2 diabetes mellitus (DMT2), is closely related to obesity. Insulin resistance and inflammation that occur in obese patients can be treated with SG procedures. Post-SG weight loss can reduce the lipo apoptotic process and can improve the function of pancreas β cells. The omentum is rich in potential mesenchymal stem cells and is rich in anti-inflammatory cytokines, and various growth factors, so the omentoplasty procedure is believed to be able to provide a regenerating effect on the pancreatic tissue so that the performance of the pancreas can be optimal.

Methods: An experimental study with 18 rats which were divided into control and treatment groups. The treatments were sleeve gastrectomy and pancreatic omentoplasty. Furthermore, analysis of body weight and levels of IL-10 and HOMA IR was carried out with the help of SPSS software version 25 univariate and bivariate.

Results: There was a difference in mean body weight, levels of IL-10, and HOMA IR before and after treatment, p<0.001.

Conclusion: Omentoplasty is effective in improving the condition of diabetes mellitus with obesity after sleeve gastrectomy surgery in vivo.


Obesity Diabetes mellitus Sleeve gastrectomy Pancreatic omentoplasty

Article Details

How to Cite
Adi Putranto, I. K., K. Heri Nugroho, & Abdul Mughni. (2022). Effects of Pancreatic Omentoplasty on Diabetes Mellitus with Obesity after Sleeve Gastrectomy: An In Vivo Study. Bioscientia Medicina : Journal of Biomedicine and Translational Research, 6(10), 2274-2278.